Author: Nicole Jupe
Dangers of synthetic cannabinoids
Synthetic cannabinoids change frequently and Quest works to stay current with drug-use patterns by adding compounds to our drug test panels.
Avoid common substance abuse program mistakes
Mark A. de Bernardo discusses tips to create an effective workplace policy and substance abuse prevention program in our recent webinar.
Workplace opioid use is costing employers
A Wall Street Journal article highlights the impact of employees' heroin and opioids use in the workplace, citing recent Drug Testing Index data.
Webinar insights: Tracking the trends
Dr. Barry Sample, Director of Science and Technology, reviewed key data and insights from the Quest Diagnostics Drug Testing Index.
Online drug testing solutions made simple
We offer online solutions for each step of the drug testing process including orders, collection site matches, status checks, images and results.
Marijuana positivity increases
Marijuana positivity increases 6.2% nationally in urine drug tests, but by double digits in Colorado and Washington reports Drug Testing Index.
Positivity is up for the first time in a decade
After years of declines, the prevalence of positive workforce drug tests is increasing according to the Quest Diagnostics Drug Testing Index data.
Webinar: Tracking the trends
Industry expert Dr. Barry Sample discusses the latest data from the Quest Diagnostics Drug Testing Index.
Webinar: 12 common (and costly) employer mistakes
Mark A. de Bernardo discusses how employers can avoid common pitfalls and maximize the effectiveness of substance-abuse prevention programs.
Workforce drug test positivity rate increases
The Quest Diagnostics Drug Testing Index showed the percentage of positive drug tests among American workers has increased for the first time in more than a decade.
